TrialBMJ open2024

Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults.

Cheryl Carcel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.